Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.5300
+0.0060 (1.15%)
Aug 13, 2026, 5:29 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 154.71 million as of August 13, 2026. Its market cap has increased by 9.89% in one year.
Market Cap
154.71M
Enterprise Value
88.60M
Revenue
13.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 154.71M, a decrease of -26.33%. That is a compound annual growth rate of -3.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 154.71M | 43.24% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 209.14M |
| Alzinova AB | 206.69M |
| Initiator Pharma | 177.29M |
| Abera Bioscience AB | 168.91M |
| Elicera Therapeutics AB | 168.84M |
| Xintela AB | 160.63M |
| Diamyd Medical AB | 158.70M |
| Nanologica AB | 148.93M |